In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: A basic research approach

Urological Research

Volumn 35, Issue 1, 2007, Pages 49-54

  Gratzke, Christian ^a   Ückert, Stefan ^b   Kedia, Giorgi ^b   Reich, Oliver ^a   Schlenker, Boris ^a   Seitz, Michael ^a   Becker, Armin J ^a   Stief, Christian G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cyclic GMP; Human ureter; PDE5 inhibitors; Phosphodiesterase (PDE) isoenzymes; Urinary stone disease

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE V INHIBITOR; POTASSIUM CHLORIDE; SCOPOLAMINE BUTYL BROMIDE; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EVALUATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MUSCLE LEVEL; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION; TISSUE LEVEL; URETER; UROLITHIASIS;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; BUTYLSCOPOLAMMONIUM BROMIDE; CARBOLINES; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE DONORS; NITROPRUSSIDE; NUCLEOTIDES, CYCLIC; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; POTASSIUM CHLORIDE; PURINES; SULFONES; TRIAZINES; URETER;

EID: 33846953220     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-006-0073-1     Document Type: Article

References (29)

1. Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333-344
2. Coll DM, Varanelli MJ, Smith RC (2002) Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol 178:101-103
3. Roberts WW, Cadeddu JA, Micali S, Kavoussi LR, Moore RG (1998) Ureteral stricture formation after removal of impacted calculi. J Urol 159:723-726
4. Porpiglia F, Destefanis P, Fiori C, Fontana D (2000) Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 56:579-582
5. Sivrikaya A, Celik OF, Sivrikaya N, Ozgur GK (2003) The effect of diclofenac sodium and papaverine on isolated human ureteric smooth muscle. Int Urol Nephrol 35:479-483
6. Ahmad M, Chaughtai MN, Khan FA (1991) Role of prostaglandin synthesis inhibitors in the passage of ureteric calculus. J Pak Med Assoc 41:268-270
7. Cervenakov I, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P (2002) Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker - Tamsulosin. Int Urol Nephrol 34:25-29
8. Dellabella M, Milanese G, Muzzonigro G (2003) Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 170:2202-2205
9. Pozzan T, Rizzuto R, Volpe P, Meldolesi J (1994) Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 74:595-636
10. Schmidt HH, Lohmann SM, Walter U (1993) The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta 1178:153-175
11. Briganti A, Salonia A, Deho' F, Zanni G, Barbieri L, Rigatti P, Montorsi F (2005) Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction. World J Urol 23:374-384
12. Sairam K, Kulinskaya E, McNicholas TA, Boustead GB, Hanbury DC (2002) Sildenafil influences lower urinary tract symptoms. BJU Int 90:836-839
13. McVary T, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes B (2006) The efficacy and safety of tadalafil administered once a day for lower urinary tract symptoms (LUTS) in men with benign prostatic hyperplasia. Eur Urol 5(Suppl 2):196
14. Truss MC, Stief CG, Uckert S, Becker AJ, Wefer J, Schultheiss D, Jonas U (2001) Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside. World J Urol 19:344-350
15. Berman JR, Berman LA, Lin H, Flaherty E, Lahey N, Goldstein I, Cantey-Kiser J (2001) EVect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 27:411-420
16. Taher A, Schulz-Knappe P, Meyer M, Truss M, Forssmann WG, Stief CG, Jonas U (1994) Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol 12:286-291
17. Kuhn R, Uckert S, Stief CG, Truss MC, Lietz B, Bischoff E, Schramm M, Jonas U (2000) Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res 28:110-115
18. Saighi D, Zerbib M, Thiounn N, Flam T, Conquy S, Jacob L, l'Ava-Santucci J, Debre B, nh-Xuan AT (2000) In vitro study of the modulation of human ureteral tonus by nitric oxide and zaprinast, a phosphodiesterase inhibitor. Prog Urol 10:1161-1168
19. Becker AJ, Stief CG, Meyer M, Truss MC, Forssmann WG, Jonas U (1998) The effect of the specific phosphodiesterase-IV-inhibitor rolipram on the ureteral peristalsis of the rabbit in vitro and in vivo. J Urol 160:920-925
20. Nicholson CD, Challiss RA, Shahid M (1991) Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol Sci 12:19-27
21. Jeremy JY, Ballard SA, Naylor AM, Miller MA, Angelini GD (1997) Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 79:958-963
22. Chuang AT, Strauss JD, Murphy RA, Steers WD (1998) Sildenafil, a type-5 CGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 160:257-261
23. Stief CG, Uckert S, Truss MC, Becker AJ, Machtens S, Jonas U (1996) A possible role for nitric oxide in the regulation of human ureteral smooth muscle tone in vitro. Urol Res 24:333-337
24. Lau LC, Adaikan PG (2006) Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum. Eur J Pharmacol 541(3):184-190
25. Nies AT, Spring H, Thon WF, Keppler D, Jedlitschky G (2002) Immunolocalization of multidrug resistance protein 5 in the human genitourinary system. J Urol 167(5):2271-2275
26. Dosda R, Marti-Bonmati L, Ronchera-Oms CL, Molla E, Arana E. (2003) Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol 13(2):294-298
27. Fuessl HS (2006) Emergency checklist: renal and ureteral colic. MMW Fortschr Med 41:31-32
28. Wanajo I, Tomiyama Y, Tadachi M, Kobayashi M, Yamazaki Y, Kojima M, Shibata N (2005) The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics. Urol Res 33(6):409-414
29. Holdgate A, Oh CM (2005) Is there a role for antimuscarinics in renal colic? A randomized controlled trial. J Urol 174(2):572-575, discussion 575